Gynaecological Cancer Awareness Month 2026: Understanding the Five Main Gynaecological Cancers

Gynaecological cancers can affect different parts of the female reproductive system, yet awareness of their symptoms and risk factors remains limited. Some warning signs, such as unusual bleeding, persistent bloating or pelvic pain, may also be mistaken for common health concerns, which can delay medical attention.

Observed in September, Gynaecological Cancer Awareness Month encourages women to understand their bodies, recognise persistent changes and seek timely medical advice. To help, this blog explains the five main types of gynaecological cancer: cervical, ovarian, uterine, vaginal and vulval cancer, along with their symptoms, risk factors and approaches to prevention and early detection.

What is Gynaecological Cancer Awareness Month?

Gynaecological Cancer Awareness Month is observed throughout September to improve understanding of cancers that affect the female reproductive system. The month focuses on helping women recognise possible symptoms, understand their individual risks and know when changes in their body deserve medical attention. It also draws attention to the importance of timely diagnosis, appropriate treatment and access to specialist care.

The need for awareness is especially important because these cancers do not all present in the same way. Some may cause noticeable changes such as unusual vaginal bleeding, while others can begin with less specific symptoms such as persistent bloating or pelvic discomfort. In addition, most gynaecological cancers do not have established screening tests for the general population, which makes awareness of persistent or unusual symptoms particularly valuable.

Rather than creating fear, the purpose of the month is to help women feel more informed about their gynaecological health. Knowing what is normal for your body, recognising when something changes and seeking medical advice when a symptom persists can help ensure that concerns are evaluated without unnecessary delay.

The Five Main Types of Gynaecological Cancer

Gynaecological cancers begin in different parts of the female reproductive system. Although they are grouped together, they do not behave in the same way, and their symptoms can differ considerably.

1. Cervical Cancer

Cervical cancer develops in the cervix, the lower part of the uterus that opens into the vagina. Most cases are linked to persistent infection with certain high-risk types of human papillomavirus (HPV).

Possible symptoms include unusual vaginal bleeding, bleeding after sex, bleeding between periods, abnormal vaginal discharge or pelvic discomfort. Cervical cancer is also different from most other gynaecological cancers because effective screening and prevention strategies, including HPV vaccination and cervical screening, are available.

2. Ovarian Cancer

Ovarian cancer develops in or around the ovaries and includes several different subtypes. Its symptoms may be subtle and can overlap with digestive or urinary problems, which is why persistent changes deserve attention.

Common symptoms may include:

• Persistent bloating
• Abdominal or pelvic pain
• Feeling full quickly while eating
• Changes in urinary frequency or urgency
• Unexplained changes in appetite or bowel habits

There is currently no routine population screening test recommended for ovarian cancer in women at average risk, making symptom awareness especially important.

3. Uterine or Endometrial Cancer

Uterine cancer begins in the uterus. The most common type is endometrial cancer, which develops in the lining of the uterus.

The most important warning sign is abnormal vaginal bleeding. This may include bleeding after menopause, bleeding between periods or menstrual bleeding that is noticeably different from usual.

Postmenopausal bleeding does not always mean cancer, but it should always be medically evaluated so the cause can be identified.

4. Vaginal Cancer

Vaginal cancer begins in the vagina and is relatively uncommon compared with cervical, ovarian or uterine cancer.

Symptoms may include:

• Unusual vaginal bleeding
• Abnormal discharge
• Pain during sex
• Pelvic discomfort
• A lump or growth in the vagina

Because these symptoms can occur with other conditions, diagnosis requires medical examination rather than relying on symptoms alone.

5. Vulval Cancer

Vulval cancer affects the vulva, the external female genital area. It may first appear as a persistent skin change rather than a deeper internal symptom.

Possible signs include:

• Persistent itching, burning or soreness
• A lump, ulcer or open sore
• Bleeding not related to menstruation
• Changes in the colour or texture of the vulval skin
• Pain or tenderness

Persistent vulval symptoms should not simply be treated repeatedly as an infection or irritation without medical evaluation.

Gynaecological Cancer Symptoms That Should Not Be Ignored

Gynaecological cancer symptoms can vary depending on where the cancer begins. Some changes are more specific, such as postmenopausal bleeding, while others, including bloating or pelvic discomfort, may also occur with many non-cancerous conditions. What matters is noticing symptoms that are new, persistent or unusual for you.

Unusual Vaginal Bleeding or Discharge

Seek medical advice for bleeding that is different from your usual pattern, including:

• Bleeding after menopause
• Bleeding between periods
• Bleeding after sex
• Periods that become noticeably heavier or longer
• Unusual vaginal discharge

Any bleeding after menopause should be evaluated, even though there are many possible causes other than cancer.

Persistent Abdominal or Pelvic Changes

Symptoms such as ongoing bloating, pelvic pressure or pain, feeling full unusually quickly, abdominal discomfort or changes in urinary or bowel habits may occur with ovarian and some other gynaecological cancers. These symptoms are often caused by less serious conditions, but they should be checked if they persist or keep returning.

Persistent Vulval or Vaginal Changes

Changes affecting the vulva or vagina also deserve attention, particularly if they do not settle. These may include:

• Persistent itching, burning or soreness
• A new lump, ulcer or sore
• Changes in skin colour or texture
• Pain during sex
• Unusual vaginal bleeding or discharge

Having one of these symptoms does not mean someone has cancer. However, unusual vaginal bleeding should be assessed promptly, and other symptoms that persist for around two weeks or longer, or are clearly different from what is normal for you, warrant medical evaluation.

Not All Gynaecological Cancers Have Routine Screening Tests

Screening can help detect some cancers or precancerous changes before symptoms appear, but there is no single screening test for all gynaecological cancers. Among the five main types, cervical cancer has established screening methods for the general population. For ovarian, uterine, vaginal and vulval cancers, early detection relies much more on recognising symptoms and seeking medical evaluation when something changes.

Cervical Cancer Screening

Cervical screening can identify high-risk HPV infection and precancerous changes before they develop into cancer. WHO continues to recommend HPV testing as the preferred primary screening method for cervical cancer prevention, although the exact screening schedule depends on age, medical history and the programme or guideline being followed.

Women who have received the HPV vaccine should still follow recommended cervical screening guidance because vaccination lowers risk but does not remove it completely.

Ovarian Cancer: No Routine Screening Test for Average-Risk Women

There is currently no reliable routine screening test for ovarian cancer in women without symptoms who are at average risk. Tests such as CA-125 and transvaginal ultrasound may be used when symptoms or other clinical concerns are present, but they have not been shown to work effectively as population screening tests.

Women with a strong family history or an inherited cancer-predisposition syndrome may need a different risk-assessment and follow-up approach.

Uterine, Vaginal and Vulval Cancers: Symptom Awareness Matters

Routine screening tests are also not available for uterine, vaginal or vulval cancers in women without symptoms. A Pap test does not screen for these cancers.

This makes symptom awareness especially important. Changes such as postmenopausal bleeding, persistent unusual vaginal bleeding, a new vulval lump or sore, or ongoing itching or skin changes should be assessed rather than waiting for a routine screening appointment.

The key distinction is simple: screening looks for disease before symptoms appear, while diagnostic testing investigates symptoms or abnormalities that have already been noticed. Knowing the difference can help women understand when routine screening is appropriate and when a specific symptom needs medical evaluation.

Reducing the Risk of Gynaecological Cancers

Not every gynaecological cancer can be prevented, and having one or more risk factors does not mean that someone will develop cancer. However, some steps can lower the risk of certain cancers or help identify women who may need closer follow-up.

HPV Vaccination Helps Prevent HPV-Related Cancers

Persistent infection with high-risk types of human papillomavirus (HPV) causes most cervical cancers and is also linked with some vaginal and vulval cancers. HPV vaccination helps prevent new infections with the HPV types most commonly associated with these cancers. It works best when given before exposure to HPV.

Vaccination does not replace cervical screening later in life, so women should still follow the screening schedule recommended for their age and medical history.

Know Your Family Cancer History

A strong family history of ovarian, uterine/endometrial, breast or colorectal cancer may indicate an inherited cancer-predisposition syndrome in some families. Conditions such as BRCA-related hereditary cancer syndromes and Lynch syndrome can increase the risk of certain gynaecological cancers.

Women with a significant family history should discuss it with their doctor. Genetic counselling or testing may be recommended when appropriate.

Maintain a Healthy Weight and Avoid Tobacco

Excess body weight is associated with a higher risk of endometrial cancer, while tobacco use increases the risk of several cancers overall. Maintaining a healthy weight, staying physically active and avoiding tobacco are sensible risk-reduction measures, although they cannot eliminate the possibility of developing gynaecological cancer.

The most useful approach is therefore not to focus on a single preventive measure, but to combine HPV vaccination, recommended cervical screening, awareness of family history and attention to persistent symptoms.

How are Gynaecological Cancers Diagnosed?

There is no single test that diagnoses all gynaecological cancers. The investigations depend on the symptoms, the part of the reproductive system involved and what the doctor finds during the initial assessment. In most cases, diagnosis follows a step-by-step process that begins with clinical evaluation and moves to imaging or tissue testing when needed.

Medical History and Pelvic Examination

The doctor will first ask about symptoms, menstrual or menopausal history, previous medical conditions and relevant family history. A pelvic examination may help assess the vagina, cervix, uterus, ovaries and surrounding tissues for any visible or palpable abnormalities.

Imaging and Other Diagnostic Tests

Depending on the suspected cancer, tests may include:

• Ultrasound, including transvaginal ultrasound, to examine the uterus, ovaries and other pelvic structures
• MRI or CT scans to assess the location and extent of a suspected cancer
• PET-CT in selected situations to help evaluate whether cancer has spread
• Blood tests or tumour markers, such as CA-125, when clinically appropriate

These tests provide useful information, but imaging or blood tests alone do not confirm every gynaecological cancer.

Biopsy Confirms the Diagnosis

A biopsy, in which a small tissue sample is examined by a pathologist, is usually needed to confirm cancer. The way the sample is obtained depends on where the abnormality is located.

For example, cervical abnormalities may be examined through colposcopy and biopsy, while suspected endometrial cancer may require an endometrial biopsy. Vulval or vaginal lesions may also be sampled directly.

Once cancer is confirmed, further tests help determine the type, stage and extent of disease. This information allows the multidisciplinary team to plan treatment according to the specific gynaecological cancer and the individual patient’s needs.

How are Gynaecological Cancers Treated?

Treatment is different for every gynaecological cancer. The care team considers where the cancer started, its type and stage, whether it has spread, relevant biomarker or molecular findings, and the patient’s overall health before recommending a treatment plan. For some patients, one treatment may be sufficient, while others may need a combination of approaches.

Surgery

Surgery is an important treatment for many gynaecological cancers and may be used to remove the tumour along with nearby tissue or lymph nodes when needed. The extent of surgery depends on the cancer type, stage and location. In selected early-stage cases, fertility-preserving procedures may also be considered when medically appropriate.

Radiotherapy and Chemotherapy

Radiotherapy may be used to destroy cancer cells in a specific area, either on its own or alongside other treatments. For cervical cancer, for example, chemotherapy and radiotherapy are often given together for certain locally advanced stages, with brachytherapy forming an important part of treatment in many cases.

Chemotherapy may be recommended before or after surgery, together with radiotherapy, or as a systemic treatment for cancers that have spread or returned. Its role varies considerably between cervical, ovarian, uterine, vaginal and vulval cancers.

Targeted Therapy, Immunotherapy and Hormone Therapy

Some patients may benefit from newer systemic treatments based on the biology of their cancer. Targeted therapies act on specific features that help cancer cells grow or survive, while immunotherapy helps the immune system recognise and attack cancer cells. Hormone therapy may also be useful for selected hormone-sensitive gynaecological cancers, particularly some endometrial cancers. These treatments are not appropriate for every patient and may depend on the cancer subtype, stage and biomarker results.

Why Specialist Treatment Planning Matters

Because the five gynaecological cancers can require very different treatment approaches, care is often planned by a multidisciplinary team that may include a gynaecological oncologist, medical oncologist, radiation oncologist, radiologist and pathologist.

The aim is not simply to choose a treatment for the cancer, but to find an approach that offers appropriate disease control while also considering the patient’s health, fertility, treatment side effects and quality of life.

Fertility, Sexual Health and Menopause During Gynaecological Cancer Care

Treatment for gynaecological cancer can affect more than the cancer itself. Depending on the type of cancer and treatment needed, it may also influence fertility, hormone levels, menstrual cycles, sexual health and body image. These concerns are an important part of cancer care and deserve to be discussed openly with the treating team.

Fertility Before Treatment

Some surgeries, chemotherapy and radiotherapy may reduce fertility or affect the ability to carry a pregnancy. For patients who may want children in the future, it is important to discuss fertility preservation before treatment begins, whenever it is medically appropriate and there is enough time to consider available options. These may include egg or embryo freezing, ovarian tissue preservation or fertility-sparing surgery in selected early-stage cancers.

Menstrual and Menopausal Changes

Treatment may temporarily or permanently affect ovarian function. Some women may experience irregular or absent periods, hot flushes, sleep problems, mood changes or vaginal dryness. In certain cases, treatment can lead to an earlier menopause than expected.

The care team can help explain which changes are likely with a particular treatment and how troublesome symptoms may be managed.

Sexual Health and Intimacy

Surgery, radiotherapy and systemic treatments may also affect sexual wellbeing. Some patients experience vaginal dryness, pain during sex, changes in sensation, reduced sexual desire or concerns about body image and intimacy. These effects vary widely and may be temporary or long-lasting.

Patients should feel comfortable raising these concerns with their doctor rather than assuming they simply have to live with them. Depending on the problem, supportive measures, counselling, pelvic rehabilitation or other treatments may help.

When Should You See a Doctor?

Many symptoms linked with gynaecological cancers can also occur with non-cancerous conditions. The important point is not to assume the worst, but also not to ignore a change that is unusual for you, keeps returning or does not settle.

Seek medical advice if you notice:

• Any bleeding after menopause
• Vaginal bleeding between periods, after sex or that is noticeably heavier or longer than usual
• Persistent bloating, pelvic pressure or abdominal pain
• Feeling full unusually quickly or having ongoing changes in bowel or urinary habits
• A new vulval lump, sore, ulcer or persistent itching or burning
• Unusual vaginal discharge or other changes that remain unexplained

Abnormal vaginal bleeding should be discussed with a doctor promptly. For other possible warning signs, the CDC advises seeking medical evaluation if they last for around two weeks or longer and are not normal for you.

Having one of these symptoms does not mean you have cancer. However, getting it checked can help identify the cause and determine whether any further tests are needed.

Comprehensive Gynaecological Cancer Care at RGCIRC

At Rajiv Gandhi Cancer Institute & Research Centre (RGCIRC), care for gynaecological cancers is led by experienced gynaecological oncologists and supported by medical oncology, radiation oncology, radiology and pathology specialists. The team reviews the cancer type, stage, diagnostic findings and individual health needs to plan an appropriate course of treatment.

At RGCIRC, patients have access to specialised diagnostic services, including colposcopy and biopsy, ultrasound, CT, MRI and PET-CT in selected cases. Treatment may involve open, laparoscopic or robotic surgery, chemotherapy, radiotherapy and targeted treatments according to the diagnosis and stage. Fertility-sparing approaches may also be considered for selected patients when oncologically appropriate.

By combining specialist expertise, advanced cancer care and empathy, RGCIRC aims to help women and their families understand their diagnosis, participate in treatment decisions and feel supported throughout the cancer journey.

To consult a cancer specialist at Rajiv Gandhi Cancer Institute & Research Centre, call +91-11-47022222 or visit www.rgcirc.org.

Frequently Asked Questions

When is Gynaecological Cancer Awareness Month 2026?

Gynaecological Cancer Awareness Month is observed throughout September. It aims to improve awareness of the five main gynaecological cancers, encourage symptom recognition and promote timely access to appropriate care.

What are the five main gynaecological cancers?

The five main types are cervical, ovarian, uterine or endometrial, vaginal and vulval cancer. Each begins in a different part of the female reproductive system and may have different symptoms, risk factors and treatment approaches.

Can a Pap test detect ovarian or uterine cancer?

No. A Pap test is used as part of cervical cancer screening and does not screen for ovarian, uterine, vaginal or vulval cancer.

Does postmenopausal bleeding always mean cancer?

No. Postmenopausal bleeding can have several causes, many of which are non-cancerous. However, any bleeding after menopause should be medically evaluated so the cause can be identified.

Can ovarian cancer be detected through routine ultrasound or CA-125 testing?

Transvaginal ultrasound and CA-125 may be used when symptoms or other clinical concerns are present, but they are not recommended as routine screening tests for average-risk women without symptoms.

Does HPV vaccination mean cervical screening is no longer necessary?

No. HPV vaccination significantly reduces the risk of HPV-related cervical disease, but vaccinated women should still follow recommended cervical screening guidance. WHO continues to recommend HPV testing as the preferred primary screening method for cervical cancer prevention.

Which is the best hospital for gynaecological cancer treatment in Delhi?

For patients looking for the best hospital for gynaecological cancer treatment in Delhi, it is important to choose a centre that combines specialist gynaecological oncology expertise, advanced diagnostics, multidisciplinary treatment planning and compassionate support.

At RGCIRC, women with cervical, ovarian, uterine, vaginal and vulval cancers receive care from experienced specialists supported by medical oncology, radiation oncology, pathology, imaging and supportive-care teams. Our approach combines clinical excellence, specialist expertise and empathy, helping patients and families understand their diagnosis, participate in treatment decisions and feel supported throughout care.